TGase6 Antibodies

Santa Cruz Biotechnology provides a broad selection of TGase6 monoclonal antibodies for research applications. TGase6 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TGase6, or transglutaminase 6, plays a crucial role in cellular processes such as protein cross-linking, cell adhesion, and tissue remodeling. Research has shown TGase6 involvement in neurodegenerative diseases, making it a potential therapeutic target in both basic and applied research. Understanding TGase6 function can provide insights into various pathological conditions and aid in the development of novel treatment strategies. Researchers worldwide utilize TGase6 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Advanced research techniques incorporating TGase6 monoclonal antibodies enable deeper understanding of disease progression and potential treatments. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by facilitating precise and reliable research outcomes in the scientific community.